Navigation Links
BioMedix™ Announces John Martin, MD, FACS, as Medical Director
Date:6/16/2011

SAINT PAUL, Minn., June 16, 2011 /PRNewswire/ -- BioMedix™, a health IT company focused on improving lives through integrated medical devices and software, announces the appointment of John Martin, MD, FACS, as Medical Director. A respected researcher and author, Dr. Martin is one of the only board certified Vascular Surgeons in the nation who is also the CEO of a major cardiology practice. Under Dr. Martin's leadership as Medical Director of Heart and Vascular Services and Director of Surgical Quality, Anne Arundel Medical Center (AAMC) has become a nationally recognized facility for the treatment of vascular disease. Dr. Martin has made a formidable contribution to our nation's preventive healthcare movement and will draw from his extensive expertise to provide leadership and guidance for BioMedix™ company initiatives.

"BioMedix™ continues to make a difference with its innovative products—BioMedix™ technology offers a platform for providers to collaborate to find and treat more patients with vascular disease," said Dr. Martin, "I am excited to join an organization that has long been dedicated to promoting early detection and prevention of cardiovascular events."

Joining the Anne Arundel Medical Center medical staff in 1999, Dr. Martin has served on various hospital committees, including the Strategic Planning Committee of the Board of Trustees. Dr. Martin has developed training, education and multiple research initiatives for AAMC, as well as a dedicated vascular patient unit. In 2000, he co-founded the Dare to C.A.R.E. Foundation, a nonprofit organization dedicated to informing the community about the threat and treatment of cardiovascular disease, providing free cardiovascular screenings to more than 30,000 individuals to date.

"The clinical experience and knowledge of vascular health that Dr. Martin brings to BioMedix™ will strengthen our continuing mission of advancing technology-enabled collaborative care," said John Romans, BioMedix™ President and CEO. "We are very pleased to have a medical professional of his caliber join our team."

Dr. Martin received his BS from the University of Texas at San Antonio. He then completed medical school, his residency in surgery and a fellowship in peripheral vascular surgery at the University of Texas Southwestern Medical Center in Dallas. He is board certified in vascular surgery. In his new role, Dr. Martin will be overseeing care improvement initiatives, research agendas and medical policy development for BioMedix™ medical devices and collaborative care platforms.

About BioMedix™

BioMedix™ is a leader in Health Information Technology (HIT) software, products and services that connect Podiatric Physicians, Primary Care Physicians, vascular labs, vascular specialists, hospitals and healthcare systems in a continuum of collaborative care. We provide the only integrated suite of hardware, software and online services designed to cost-effectively detect vascular disease. Our award-winning suite of medical devices, advanced practice management and Electronic Health Record (EHR) software and web-based solutions give providers a more complete view of patient care. For more information about BioMedix™ products, call 877-854-0014 or log on to www.BioMedix.com.


'/>"/>
SOURCE BioMedix
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMedix™ Now Exclusive Industry Distributor of the APMA Coding Resource Center
2. International Drug & Explosives Detection Company IDenta Corp. Announces New Representative in Japan
3. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
4. American Medical Systems Announces Large-Scale, Physician-Led Registry of Penile Implants
5. Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent
6. Endologix Announces FDA Approval of AFX™ Endovascular AAA System
7. Fuisz Announces Issuance of Patent Concerning Product Supplier Database Sharing With an On-Line Vendor
8. Generex Announces Appointment of CEO for Post-Spinout Antigen Express
9. Perrigo Announces Launch of the Generic Version of Nasacort® AQ
10. Masimo Announces Rainbow Agreement with Philips
11. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):